Vivo Capital as of Dec. 31, 2016
Portfolio Holdings for Vivo Capital
Vivo Capital holds 24 positions in its portfolio as reported in the December 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Aclaris Therapeutics (ACRS) | 29.7 | $89M | 3.3M | 27.14 | |
Ascendis Pharma A S (ASND) | 11.9 | $36M | 1.8M | 20.24 | |
Codexis (CDXS) | 8.1 | $24M | 5.3M | 4.60 | |
Nabriva Therapeutics | 8.0 | $24M | 4.0M | 5.96 | |
Eiger Biopharmaceuticals | 6.9 | $21M | 1.8M | 11.65 | |
Aimmune Therapeutics | 5.2 | $16M | 763k | 20.45 | |
Advanced Accelerat spon ads each rep 2 ord | 4.1 | $12M | 456k | 26.76 | |
Trevena | 3.4 | $10M | 1.7M | 5.88 | |
Foamix Pharmaceuticals | 3.2 | $9.5M | 855k | 11.10 | |
Regenxbio Inc equity us cm (RGNX) | 3.1 | $9.3M | 503k | 18.55 | |
Agile Therapeutics | 2.9 | $8.6M | 1.5M | 5.70 | |
Colucid Pharmaceuticals | 2.7 | $8.2M | 225k | 36.40 | |
Strongbridge Bioph shs usd | 2.4 | $7.2M | 3.0M | 2.40 | |
Capnia | 2.0 | $6.0M | 7.5M | 0.81 | |
Biopharmx | 1.6 | $4.7M | 13M | 0.37 | |
Akari Therapeutics | 1.2 | $3.7M | 528k | 7.04 | |
Pronai Therapeutics | 1.2 | $3.6M | 2.4M | 1.49 | |
Kalvista Pharmaceuticals (KALV) | 0.7 | $2.1M | 300k | 7.07 | |
Sunesis Pharmaceuticals Inc Ne | 0.6 | $1.8M | 500k | 3.62 | |
Revance Therapeutics (RVNC) | 0.5 | $1.6M | 77k | 20.70 | |
Dynavax Technologies (DVAX) | 0.5 | $1.4M | 360k | 3.95 | |
Ocera Therapeutics | 0.1 | $322k | 153k | 2.10 | |
Capnia Inc Common Stock Warrants | 0.0 | $76k | 944k | 0.08 | |
Zosano Pharma | 0.0 | $77k | 99k | 0.78 |